Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hikma Pharmaceuticals PLC

www.hikma.com

Latest From Hikma Pharmaceuticals PLC

Mylan Launches Advair Generic Wixela At 70% Discount To GSK's Branded Drug List Price

Two weeks after the product's approval, Mylan finally has launched Wixela and revealed a big price cut for the asthma and COPD medicine over the brand; the actual savings for patients remains dependent on payer negotiations and other factors.

Generic Drugs Pricing Strategies

Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Mylan’s Generic Advair Approval Showcases US FDA Efforts To Boost Complex Products

Commissioner Gottlieb previews actions agency intends to take in 2019 to smooth the regulatory and scientific pathway for generics of complex drugs, including draft guidance with recommendations on establishing active ingredient sameness.

Generic Drugs Drug Approval Standards

Generic Advair: Finally Approved, A Long Time Coming

Mylan's generic version of GlaxoSmithKline's blockbuster asthma drug was approved by the US FDA Jan. 30. Scrip's timeline tracks how the commercial value of the drug for GSK has greatly declined from its peak in 2013.

Approvals Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Hikma Pharmaceuticals PLC
  • Senior Management
  • Said Darwazah, Chmn. & CEO
    Khalid Nabilsi, CFO
    Bassam Kanaan, Chief Strategy & Corp. Dev. Officer
  • Contact Info
  • Hikma Pharmaceuticals PLC
    Phone: (44) 20 7399 2760
    1 New Burlington Pl.
    London, W1S 2HR
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register